JWBC
PDSB icon

J.W. Burns & Co’s PDS Biotechnology PDSB Stock Holding History

J.W. Burns & Co’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,300
Closed -$10.4K – 188
2025
Q3 		$10.4K Hold
10,300
– – ﹤0.01% 184
2025
Q2 		$13.7K Hold
10,300
– – ﹤0.01% 184
2025
Q1 		$12.3K Hold
10,300
– – ﹤0.01% 187
2024
Q4 		$16.8K Buy
+10,300
New +$27.3K ﹤0.01% 188

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

J.W. Burns & Co's PDSB Position: Q4 2025 in Review

J.W. Burns & Co sold out of PDS Biotechnology (PDSB) in Q4 2025, closing a stake of 10,300 shares — an estimated $10.4K sold.

J.W. Burns & Co first reported a position in PDSB in Q4 2024 and held it in 4 quarters. The position peaked at $16.8K in Q4 2024. 44 funds tracked by Wall St. Rank hold PDSB as of Q4 2025.

  • J.W. Burns & Co reported no remaining PDS Biotechnology position as of Q4 2025 after selling out during the quarter.
  • J.W. Burns & Co sold 10,300 PDS Biotechnology shares in Q4 2025, an estimated $10.4K.
  • J.W. Burns & Co first reported a position in PDS Biotechnology in Q4 2024 and held it in 4 quarters.
  • J.W. Burns & Co's PDS Biotechnology position peaked at $16.8K in Q4 2024.
  • 44 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2025.

Based on J.W. Burns & Co's 13F filing for Q4 2025, filed 12 Jan 2026.